Headlines are made when the European Commission prohibits a merger, but this is actually very rare. Clearances subject to conditions (i.e. remedies) happen ten times as frequently, but have received far less attention in academic literature. This...
more
Headlines are made when the European Commission prohibits a merger, but this is actually very rare. Clearances subject to conditions (i.e. remedies) happen ten times as frequently, but have received far less attention in academic literature. This book provides an empirical assessment of the effectiveness of merger remedies, employing a novel simulation methodology based on formal economic theory. The authors were given unprecedented access to data available to case handlers, concerning a range of remedied mergers covering 21 markets. Using this they have adapted simple simulation techniques to
Includes bibliographical references (p. 253-261) and index
Electronic reproduction; Available via World Wide Web
COVER; COPYRIGHT; Contents; Tables; Figures and boxes; Acknowledgements; Preface; 1. Mergers and remedies in the EU: an overview; 2. The literature on merger remedies; 3. Classification of merger remedies; 4. Methodology for assessment of mergers and remedies; 5. Structure and competitive process in paper and board markets; 6. Assessment of remedies adopted by the EC in paper mergers; 7. Structure and competitive process in pharmaceuticals markets; 8. Assessment of remedies adopted by the EC in pharmaceuticals mergers; 9. Conclusions and recommendations; References; Index
